Compare KITT & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KITT | AIDX |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | 51 | 14 |
| Industry | Industrial Machinery/Components | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8M | 9.2M |
| IPO Year | N/A | N/A |
| Metric | KITT | AIDX |
|---|---|---|
| Price | $1.45 | $0.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 310.5K | 241.0K |
| Earning Date | 04-16-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $0.78 |
| 52 Week High | $6.93 | $14.09 |
| Indicator | KITT | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 39.41 | 37.43 |
| Support Level | $0.75 | N/A |
| Resistance Level | $1.64 | $1.66 |
| Average True Range (ATR) | 0.14 | 0.11 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 3.03 | 51.61 |
Nauticus Robotics Inc is a technology-driven company specializing in the development of fully electric autonomous robotic solutions for subsea applications. Its portfolio includes autonomous underwater vehicles (AUVs), electric robotic manipulators, a platform-agnostic robotic operating system, and related engineering, consulting and prototype services. The Company's solutions enable autonomous operations for both commercial and defense sectors, with alignment to offshore energy and national security interests. Its addressable markets include upstream, midstream and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research and subsea mining, with current focus on oil and gas operations and defense applications.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.